Correlation Between Us Strategic and Oppenheimer Developing
Can any of the company-specific risk be diversified away by investing in both Us Strategic and Oppenheimer Developing at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Us Strategic and Oppenheimer Developing into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Us Strategic Equity and Oppenheimer Developing Markets, you can compare the effects of market volatilities on Us Strategic and Oppenheimer Developing and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Us Strategic with a short position of Oppenheimer Developing. Check out your portfolio center. Please also check ongoing floating volatility patterns of Us Strategic and Oppenheimer Developing.
Diversification Opportunities for Us Strategic and Oppenheimer Developing
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between RUSTX and Oppenheimer is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Us Strategic Equity and Oppenheimer Developing Markets in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oppenheimer Developing and Us Strategic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Us Strategic Equity are associated (or correlated) with Oppenheimer Developing. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oppenheimer Developing has no effect on the direction of Us Strategic i.e., Us Strategic and Oppenheimer Developing go up and down completely randomly.
Pair Corralation between Us Strategic and Oppenheimer Developing
Assuming the 90 days horizon Us Strategic is expected to generate 2.45 times less return on investment than Oppenheimer Developing. But when comparing it to its historical volatility, Us Strategic Equity is 1.16 times less risky than Oppenheimer Developing. It trades about 0.02 of its potential returns per unit of risk. Oppenheimer Developing Markets is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 3,705 in Oppenheimer Developing Markets on November 30, 2024 and sell it today you would earn a total of 50.00 from holding Oppenheimer Developing Markets or generate 1.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Us Strategic Equity vs. Oppenheimer Developing Markets
Performance |
| Timeline |
| Us Strategic Equity |
| Oppenheimer Developing |
Us Strategic and Oppenheimer Developing Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Us Strategic and Oppenheimer Developing
The main advantage of trading using opposite Us Strategic and Oppenheimer Developing positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Us Strategic position performs unexpectedly, Oppenheimer Developing can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oppenheimer Developing will offset losses from the drop in Oppenheimer Developing's long position.| Us Strategic vs. Pace High Yield | Us Strategic vs. Pioneer High Income | Us Strategic vs. Gmo High Yield | Us Strategic vs. Aqr Alternative Risk |
| Oppenheimer Developing vs. Deutsche Health And | Oppenheimer Developing vs. Health Care Fund | Oppenheimer Developing vs. Schwab Health Care | Oppenheimer Developing vs. Baillie Gifford Health |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |